Imaging treatment effects in Alzheimer's disease

This publication has 74 references indexed in Scilit:

• Regional cerebral blood flow in Alzheimer’s disease: Comparison between short and long-term donepezil therapy
  Annals of Nuclear Medicine, 2006
• SPECT Follow-Up Study of Cerebral Blood Flow Changes During Donepezil Therapy in Patients with Alzheimer's Disease
  Journal of Neuroimaging, 2006
• Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer’s disease
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2005
• Medial Temporal Lobe Atrophy and APOE Genotype Do Not Predict Cognitive Improvement upon Treatment with Rivastigmine in Alzheimer’s Disease Patients
  Dementia and Geriatric Cognitive Disorders, 2005
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
  Annals of Neurology, 2004
• Galantamine Provides Sustained Benefits in Patients with ‘Advanced Moderate’ Alzheimer’s Disease for at Least 12 Months
  Dementia and Geriatric Cognitive Disorders, 2003
• Imaging of Nicotinic and Muscarinic Receptors in Alzheimer's Disease: Effect of Tacrine Treatment
  Dementia and Geriatric Cognitive Disorders, 1997
• Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: A pilot double blind transdermal nicotine positron emission tomography study
  Neuropsychology Review, 1996
• Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography
  Acta Psychiatrica Scandinavica, 1991
• Neuropathological stageing of Alzheimer-related changes
  Acta Neuropathologica, 1991